Turning Point Therapeutics
$0.00 (0.00%) As of 11:00 AM UTC pre-market
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPTX and other ETFs, options, and stocks.
About TPTX
Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor.
CEO
Athena M. Countouriotis
Employees
250
Headquarters
San Diego, California
Founded
2013
TPTX Key Statistics
Market cap
3.73B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.46M
High today
$75.28
Low today
$74.95
Open price
$75.15
Volume
1.52M
52 Week high
$82.20
52 Week low
$23.77
Analyst ratings
100%
of 9 ratings
Buy
0%
Hold
100%
Sell
0%
TPTX Earnings
-$1.58
-$1.05
-$0.53
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, After Hours